Your browser doesn't support javascript.
loading
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Dieci, Maria Vittoria; Tsvetkova, Vassilena; Griguolo, Gaia; Miglietta, Federica; Tasca, Giulia; Giorgi, Carlo Alberto; Cumerlato, Enrico; Massa, Davide; Lo Mele, Marcello; Orvieto, Enrico; Guarneri, Valentina; Conte, Pierfranco.
Afiliação
  • Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Tsvetkova V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Anatomy and Histology Unit, Padova Hospital, Padova, Italy.
  • Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Miglietta F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Tasca G; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Giorgi CA; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Cumerlato E; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Massa D; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Lo Mele M; Anatomy and Histology Unit, Padova Hospital, Padova, Italy.
  • Orvieto E; Pathology Unit, Ulss 5 Polesana, Rovigo, Italy.
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy. Electronic address: valentina.guarneri@unipd.it.
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
Eur J Cancer ; 136: 7-15, 2020 09.
Article em En | MEDLINE | ID: mdl-32622323
ABSTRACT

BACKGROUND:

Tumour infiltrating lymphocytes (TILs) are an established prognostic biomarker for triple-negative breast cancer (TNBC). We evaluated the role of programmed cell-death ligand-1 (PD-L1), CD8 and FOXP3 expression in refining a prognostic model for non-metastatic TNBC beyond classic factors and TILs.

METHODS:

Primary tumour samples from 244 early patients with TNBC, all treated with surgery and chemotherapy, were collected. Stromal TILs were evaluated on haematoxylin-eosin slides according to guidelines. PD-L1, CD8 and FOXP3 were assessed by immunohistochemistry and evaluated by digital pathology.

RESULTS:

TILs, PD-L1, CD8 and FOXP3 were positively correlated with each other (P < 0.001). TILs were confirmed as an independent prognostic factor. When PD-L1, CD8 and FOXP3 were added to multivariable models including classic factors (age, stage, histologic grade) and TILs, PD-L1 provided the largest amount of additional prognostic information likelihood ratio χ2 4.60, P = 0.032 (in a model including classic factors and TILs 10% increments) and likelihood ratio χ2 6.50, P = 0.011 (in a model including classic factors and TILs >30% versus <30%). In the subset of patients treated with neoadjuvant chemotherapy, FOXP3 provided further prognostic information beyond classic factors, TILs and pathological complete response (pCR) (likelihood ratio χ2 5.01, P = 0.025). For patients who did not achieve a pCR, the expression of CD8 and PD-L1 was significantly increased from baseline to residual disease.

CONCLUSIONS:

Beyond clinicopathological factors and TILs, other immune biomarkers may add prognostic information for early TNBC. The increased PD-L1 expression on residual disease after neoadjuvant chemotherapy strengthens the rationale of testing immune checkpoint inhibitors in the post-neoadjuvant setting.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Fatores de Transcrição Forkhead / Antígeno B7-H1 / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Fatores de Transcrição Forkhead / Antígeno B7-H1 / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2020 Tipo de documento: Article